Publications
2019
scSLAM-seq reveals core features of transcription dynamics in single cells, Erhard F., Baptista M.A., Krammer T. Hennig T. ,Lange M., Arampatzi P., Jürges C.S., Theis F.J., Saliba A.E., Dölken L.; Nature 571, 419-423 (2019). https://www.nature.com/articles/s41586-019-1369-y
The complex of MCMV proteins and MHC class I evades NK cell control and drives the evolution of virus-specific activating Ly49 receptors, Železnjak J., Juranić Lisnić V., Popović B., Lisnić B., Babić M., Halenius A., L’Hernault A., Lenac Roviš T., Hengel H., Erhard F., Redwood A.J., Vidal S.M., Dölken L., Krmpotić A., Jonjić S., Journal of Experimental Medicine 216, 1809–1827 (2019). https://rupress.org/jem/article/216/8/1809/120585
Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models, Lübke M., Spalt S., Kowalewski D.J., Zimmermann C., Bauersfeld L., Nelde A., Bichmann L., Marcu A., Peper J.K., Kohlbacher O., Walz J.S., Le-Trilling V.T.K., Hengel H., Rammensee H.-G., Stevanović S., Halenius A., Journal of Experimental Medicine 217, e20191164 (2019). https://rupress.org/jem/article/217/3/e20191164/133529/Identification
2020
Differential effects of Belatacept on virus-specific memory versus de novo allo-specific T cell responses of kidney transplant recipients and healthy donors, Kühne J.F., Neudörfl C., Beushausen K., Keil J., Malysheva S., Wandrer F., Haller H., Messerle M., Blume C., Neuenhahn M., Schlott F., Hammershmidt W., Zeidler R., Falk C.S., ScienceDirect, 61, 101291 (2020). https://www.sciencedirect.com/science/article/pii/S0966327419301674
How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation, Einsele H., Ljungmann P., Boeckh M., Blood 135, 1619–1629 (2020). https://ashpublications.org/blood/article/135/19/1619/452747/How-I-treat-CMV-reactivation-after-allogeneic
Identification of the Cryptic HLA-I Immunopeptidome, Erhard F., Dölken L., Schilling B., Schlosser A., AACR Publications 8, 1018-1026 (2020).
https://cancerimmunolres.aacrjournals.org/content/8/8/1018
2021
COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses. Bonifacius A., Tischer-Zimmermann S., Dragon A.C., Gussarow D., Vogel A., Krettek U., Gödecke N., Yilmaz M., Kraft A.R.M., Hoeper M.M., Pink I., Schmidt J.J., Li Y., Welte T., Maecker-Kolhoff B., Martens J., Berger M.M., Lobenwein C., Stankov M.V., Cornberg M., David S., Behrens G.M.N., Witzke O., Blasczyk R., Eiz-Vesper B., Immunity, 54: 340–354. (2021) https://www.sciencedirect.com/science/article/pii/S1074761321000315?via%3Dihub
Cytomegalovirus restricts ICOSL expression on antigen-presenting cells disabling T cell co-stimulation and contributing to immune evasion. Angulo G., Zeleznjak J., Martínez-Vicente P., Puñet-Ortiz J., Hengel H., Messerle M., Oxenius A., Jonjic S., Krmpotic A., Engel P., Angulo A., Elife. 18;10:e59350. doi: 10.7554/eLife.59350 (2021) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840182/
